These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20925531)

  • 21. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.
    Wang Z; Su F; Rogiers P; Vincent JL
    Crit Care Med; 2007 Nov; 35(11):2594-600. PubMed ID: 17901839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
    Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
    Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study.
    Schouten M; van't Veer C; Roelofs JJ; Levi M; van der Poll T
    Crit Care; 2010; 14(4):R145. PubMed ID: 20682036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
    Kunsdorf-Wnuk A; Marzec-Lewenstein E; Arct-Danielak D; Musioł E; Bohatyrewicz R; Becht R
    Med Sci Monit; 2005 Aug; 11(8):CS49-55. PubMed ID: 16049385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.
    Nuermberger E
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):134S-139S. PubMed ID: 16305283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated protein C therapy in a rat heat stroke model.
    Chen CM; Hou CC; Cheng KC; Tian RL; Chang CP; Lin MT
    Crit Care Med; 2006 Jul; 34(7):1960-6. PubMed ID: 16715032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Ott A
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2196-7. PubMed ID: 11727624
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammation and coagulation: implications for the septic patient.
    Dellinger RP
    Clin Infect Dis; 2003 May; 36(10):1259-65. PubMed ID: 12746771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
    McCullers JA
    J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pneumococcal pneumonia.
    Pallares R
    Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment.
    Dallaire F; Ouellet N; Simard M; Bergeron Y; Bergeron MG
    J Infect Dis; 2001 Jan; 183(1):70-7. PubMed ID: 11087202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue factor pathway inhibitor and bacterial infection.
    Maroney SA; Mast AE
    J Thromb Haemost; 2011 Jan; 9(1):119-21. PubMed ID: 21210950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model.
    Fernández JA; Xu X; Liu D; Zlokovic BV; Griffin JH
    Blood Cells Mol Dis; 2003; 30(3):271-6. PubMed ID: 12737945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia.
    Yang Z; Bedugnis A; Levinson S; Dinubile M; Stossel T; Lu Q; Kobzik L
    J Infect Dis; 2019 Sep; 220(9):1498-1502. PubMed ID: 31287867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteremic pneumococcal pneumonia and antibiotics].
    Mella SM; Blamey RD; Paiva OM; Yañez JV; Chabouty HG
    Rev Med Chil; 2004 Oct; 132(10):1258-9; author reply 1260-1. PubMed ID: 15631217
    [No Abstract]   [Full Text] [Related]  

  • 36. A patient full of surprises: a body packer with cocaine intoxication, pneumococcal pneumonia and HIV infection.
    Luginbühl M; Junker T; Keller DI
    BMC Emerg Med; 2018 Sep; 18(1):29. PubMed ID: 30180803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C inhalation: a novel therapeutic strategy for acute lung injury.
    Bo L; Bian J; Li J; Wan X; Zhu K; Deng X
    Med Sci Monit; 2011 Jun; 17(6):HY11-3. PubMed ID: 21629195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?
    Harbarth S; Garbino J; Pittet D; Pugin J
    J Infect Dis; 2004 May; 189(9):1743. PubMed ID: 15116314
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant human activated protein C in a liver transplant recipient in the immediate postoperative period.
    Rewari V; Milan ZB; Attia M; Davies M
    Anaesth Intensive Care; 2011 Jul; 39(4):771-2. PubMed ID: 21823404
    [No Abstract]   [Full Text] [Related]  

  • 40. Care in the chicken coop.
    Collins NP; Warner B; Wilson SF
    Med J Aust; 2002 Dec 2-16; 177(11-12):632. PubMed ID: 12523323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.